Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

101 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Natural adjuvants: endogenous activators of dendritic cells.
Gallucci S, Lolkema M, Matzinger P. Gallucci S, et al. Nat Med. 1999 Nov;5(11):1249-55. doi: 10.1038/15200. Nat Med. 1999. PMID: 10545990
Epithelial cell-specific laminin 5 is required for survival of early thymocytes.
Kim MG, Lee G, Lee SK, Lolkema M, Yim J, Hong SH, Schwartz RH. Kim MG, et al. J Immunol. 2000 Jul 1;165(1):192-201. doi: 10.4049/jimmunol.165.1.192. J Immunol. 2000. PMID: 10861052
Bridging the Translational Divide in Oncology: In Vivo Testing of Chemo-sensitivity.
Sleijfer S, Lolkema M. Sleijfer S, et al. Among authors: lolkema m. Clin Cancer Res. 2020 Aug 1;26(15):3897-3898. doi: 10.1158/1078-0432.CCR-20-1452. Epub 2020 Jun 1. Clin Cancer Res. 2020. PMID: 32482905
ESMO Clinical Research Observatory (ECRO): improving the efficiency of clinical research through rationalisation of bureaucracy.
Perez-Gracia JL, Awada A, Calvo E, Amaral T, Arkenau HT, Gruenwald V, Bodoky G, Lolkema MP, Di Nicola M, Penel N, Vera R, Sanmamed MF, Douillard JY. Perez-Gracia JL, et al. Among authors: lolkema mp. ESMO Open. 2020 May;5(3):e000662. doi: 10.1136/esmoopen-2019-000662. ESMO Open. 2020. PMID: 32393574 Free PMC article. Review.
Intratumoral Comparison of Nanoparticle Entrapped Docetaxel (CPC634) with Conventional Docetaxel in Patients with Solid Tumors.
Atrafi F, van Eerden RAG, van Hylckama Vlieg MAM, Oomen-de Hoop E, de Bruijn P, Lolkema MP, Moelker A, Rijcken CJ, Hanssen R, Sparreboom A, Eskens FALM, Mathijssen RHJ, Koolen SLW. Atrafi F, et al. Among authors: lolkema mp. Clin Cancer Res. 2020 Jul 15;26(14):3537-3545. doi: 10.1158/1078-0432.CCR-20-0008. Epub 2020 Apr 22. Clin Cancer Res. 2020. PMID: 32321718
Preferences to receive unsolicited findings of germline genome sequencing in a large population of patients with cancer.
Bijlsma R, Wouters R, Wessels H, Sleijfer S, Beerepoot L, Ten Bokkel Huinink D, Cruijsen H, Heijns J, Lolkema MP, Steeghs N, van Voorthuizen T, Vulink A, Witteveen E, Ausems M, Bredenoord A, May AM, Voest E. Bijlsma R, et al. Among authors: lolkema mp. ESMO Open. 2020 Apr;5(2):e000619. doi: 10.1136/esmoopen-2019-000619. ESMO Open. 2020. PMID: 32312756 Free PMC article.
68Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients.
de Jong AC, Smits M, van Riet J, F├╝tterer JJ, Brabander T, Hamberg P, van Oort IM, de Wit R, Lolkema MP, Mehra N, Segbers M, van der Veldt AAM. de Jong AC, et al. Among authors: lolkema mp. J Nucl Med. 2020 Mar 13:jnumed.119.241109. doi: 10.2967/jnumed.119.241109. Online ahead of print. J Nucl Med. 2020. PMID: 32169916
Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer.
van Geel RMJM, van Brummelen EMJ, Eskens FALM, Huijberts SCFA, de Vos FYFL, Lolkema MPJK, Devriese LA, Opdam FL, Marchetti S, Steeghs N, Monkhorst K, Thijssen B, Rosing H, Huitema ADR, Beijnen JH, Bernards R, Schellens JHM. van Geel RMJM, et al. Among authors: lolkema mpjk. Br J Cancer. 2020 Apr;122(8):1166-1174. doi: 10.1038/s41416-020-0776-z. Epub 2020 Mar 9. Br J Cancer. 2020. PMID: 32147669
Impact of panel design and cut-off on tumour mutational burden assessment in metastatic solid tumour samples.
Mankor JM, Paats MS, Groenendijk FH, Roepman P, Dinjens WNM, Dubbink HJ, Sleijfer S; CPCT Consortium, Cuppen E, Lolkema MPJK. Mankor JM, et al. Among authors: lolkema mpjk. Br J Cancer. 2020 Mar;122(7):953-956. doi: 10.1038/s41416-020-0762-5. Epub 2020 Feb 25. Br J Cancer. 2020. PMID: 32094484
101 results
Jump to page